U.S. FDA panel revisits Avandia, likely too late for diabetes drug

U.S. FDA panel revisits Avandia, likely too late for diabetes drug

Submitted by admin on June 6, 2013 - 10:47am
Source: 
Reuters
News Tags: 
advisory panels
FDA
diabetes
GSK
Avandia
Headline: 
U.S. FDA panel revisits Avandia, likely too late for diabetes drug

Do Not Allow Advertisers to Use My Personal information